Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;14(2):e1769.
doi: 10.1002/wnan.1769. Epub 2021 Dec 22.

Catalytic antimicrobial therapy using nanozymes

Affiliations
Review

Catalytic antimicrobial therapy using nanozymes

Qian Wang et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Mar.

Abstract

Nanozymes are nanomaterials with enzyme-like characteristics, which catalyze the conversion of enzyme substrates and follow enzymatic kinetics under physiological conditions. As a new generation of artificial enzymes, nanozymes provide alternative approaches for those upon enzymatic catalysis. Compared with natural enzymes, nanozymes have the advantages of simple preparation, good stability and low cost, which makes nanozymes promising for application in many fields, such as antimicrobial infection treatment. Many studies have reported that nanozymes are capable of killing a number of pathogenic bacteria with resistance, fungi as well as viruses, and have shown great curative effects for diseases caused by these pathogens. Herein, we summarize the application of nanozymes for antibacterial, antiviral, and antifungal therapies and outline the issues needing resolution in the future. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.

Keywords: antibacterial; antifungal; antiviral; catalytic therapy; nanozymes.

PubMed Disclaimer

References

REFERENCES

    1. Abdelhamid, H. N., Mahmoud, G. A. E., & Sharmoukh, W. (2020). A cerium-based MOFzyme with multi-enzyme-like activity for the disruption and inhibition of fungal recolonization. Journal of Materials Chemistry B, 8(33), 7548-7556. https://doi.org/10.1039/d0tb00894j
    1. Adamson, C. S., Chibale, K., Goss, R. J. M., Jaspars, M., Newman, D. J., & Dorrington, R. A. (2021). Antiviral drug discovery: Preparing for the next pandemic. Chemical Society Reviews, 50(16), 9346-9346. https://doi.org/10.1039/d1cs90064a
    1. Al-Anazi, K. A., & Al-Jasser, A. M. (2014). Infections caused by acinetobacter baumannii in recipients of hematopoietic stem cell transplantation. Frontiers in Oncology, 4, 186. https://doi.org/10.3389/fonc.2014.00186
    1. Amieva, M., & Peek, R. M. (2016). Pathobiology of helicobacter pylori-induced gastric cancer. Gastroenterology, 150(1), 64-78. https://doi.org/10.1053/j.gastro.2015.09.004
    1. Arias, C. A., & Murray, B. E. (2009). Antibiotic-resistant bugs in the 21st century-A clinical super-challenge. The New England Journal of Medicine, 360(5), 439-443. https://doi.org/10.1056/NEJMp0804651

Publication types

MeSH terms

Substances

LinkOut - more resources